Zaki Nakib

Possui graduação em pharmacy pela University Of Batna(2007), mestradopela Université Paris Descartes(2010) e mestrado em Master Biology Health pela Université Paris-Est Marne la Vallée(2009). Atualmente é Scientific Journal Referee da Journal of Ocular Pharmacology and Therapeutics. Tem experiência na área de Farmácia, com ênfase em Análise Toxicológica.

Informações coletadas do Lattes em 10/11/2022

Acadêmico

Formação acadêmica

Mestrado

2009 - 2010

Université Paris Descartes
Orientador: Fançoise brignole Baudouin and Christophe Baudouin
Grande área: Ciências da Saúde / Área: Farmácia / Subárea: Análise Toxicológica.

Mestrado em Master Biology Health

2008 - 2009

Université Paris-Est Marne la Vallée
Orientador: françoise brignole baudouin and christophe baudouin
Grande área: Ciências Biológicas / Área: Farmacologia / Subárea: Toxicologia. Grande Área: Ciências da Saúde / Área: Farmácia. Grande Área: Ciências da Saúde / Área: Farmácia / Subárea: Análise Toxicológica.

Graduação em pharmacy

2002 - 2007

University Of Batna

Formação complementar

2011 - 2011

MBA em intensive preparation for TOEFL. (Carga Horária: 24h). , MBA Center Brussels.

2007 - 2008

Intensive courses of English. , University Of Batna.

Idiomas

Bandeira representando o idioma Inglês

Compreende Bem, Fala Razoavelmente, Lê Bem, Escreve Bem.

Bandeira representando o idioma Francês

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Árabe

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Áreas de atuação

Grande área: Ciências da Saúde / Área: Farmácia / Subárea: Análise Toxicológica.

Grande área: Ciências Biológicas / Área: Farmacologia / Subárea: Farmacologia Bioquímica e Molecular.

Grande área: Ciências Biológicas / Área: Imunologia / Subárea: Imunologia Celular.

Grande área: Ciências Biológicas / Área: Imunologia / Subárea: Imunoquímica.

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica/Especialidade: Oftalmologia.

Participação em eventos

European Glaucoma Society Congress. A comparative toxicological study between benzalkonium- and polyquad-containing antiglaucoma fixed combinations of travoprost 0.004%/timolol 0.5% on conjunctival epithelial cells using microtitration fluorimetric assays on live cells. 2010. (Congresso).

Produções bibliográficas

  • Brignole-Baudouin, Françoise ; Riancho, Luisa ; Liang, Hong ; NAKIB, Z. ; Baudouin, Christophe . Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination. Journal of Ocular Pharmacology and Therapeutics , v. 27, p. 273-280, 2011.

  • NAKIB, Z. ; Liang, Hong ; Baudouin, Christophe ; Brignole-Baudouin, Françoise . A comparative toxicological study between benzalkonium- and polyquad-containing antiglaucoma fixed combinations of travoprost 0.004%/timolol 0.5% on conjunctival epithelial cells using microtitration fluorimetric assays on live cells. 2010. (Apresentação de Trabalho/Congresso).

Projetos de pesquisa

  • 2010 - Atual

    Set up of new In Vitro dry eyes model, Descrição: Dry eye is a multifactorial disease that may be caused by eye drop preservatives. Our aim was to establish an in vitro dry eye model and to evaluate the toxicity of the combination of both desiccation and benzalkonium chloride (BAK) chemical stress. , Situação: Em andamento; Natureza: Pesquisa. , Integrantes: Zaki Nakib - Coordenador / Brignole-Baudouin, Françoise - Integrante / Baudouin, Christophe - Integrante.

  • 2009 - 2009

    Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination, Situação: Concluído; Natureza: Pesquisa. , Integrantes: Zaki Nakib - Coordenador / Brignole-Baudouin, Françoise - Integrante / Riancho, Luisa - Integrante / Liang, Hong - Integrante / Baudouin, Christophe - Integrante., Número de produções C, T & A: 1

Histórico profissional

Experiência profissional

2010 - 2010

Centre de Recherche Institut de la Vision, URM_S968 Inserm

Vínculo: Scholarship, Enquadramento Funcional: Master student, Regime: Dedicação exclusiva.

Outras informações:
Dry eye is a multifactorial disease that may be caused by eye drop preservatives. Our aim was to establish an in vitro dry eye model and to evaluate the toxicity of the combination of both desiccation and benzalkonium chloride (BAK) chemical stress. BAK has surfactant and preservative properties in eyedrops and its toxicity to the ocular surface is well known. Using a conjunctival cell line, we investigated cell viability, apoptosis and oxidative stress with cold light- and flow- cytometry (FCM) and the expression of the chemokine CCL2 and its receptor CCR2 with FCM and immunofluorescence. The results showed that desiccation induces apoptosis , loss of viability without oxidative stress and membrane CCL2/CCR2 overexpression. The combination of the two stresses revealed a toxicityincrease and a potentiating toxic effect through a drastic decrease in cell viability, a significant increase of apoptosis, oxidative stress and of the expression of the inflammatory chemokine CCL2 and CCR2. This preliminary study confirms the importance of this potentiating toxic effect between dessication and preservative and could offer a new model to investigate and better understand the vicious circle of hyperosmolarity and inflammation observed in dry eye patients.

2009 - 2009

Université Paris Descartes

Vínculo: Scholarship, Enquadramento Funcional: Master student, Regime: Dedicação exclusiva.

Outras informações:
Long-term treatment of glaucoma with antiglaucomatous eye drops is known to induce toxic side effects on the ocular surface as allergy, dry eye and inflammation. Numerous studies demonstrated that the preservative, benzalkonium chloride (BAC), commonly used in eyes drops is the main actor of this toxicity that may affect patient compliance to treatment. Thus, laboratories try to develop new formulations in order to minimize side effects. The purpose of this work was to evaluate in vitro on conjunctival epithelial cells, the toxicological profile of three eyes drops with different BAC concentration and with a new preservative promising to be less toxic than BAC. We used the microtitration in fluorescence assay on live cells to assess cytotoxicity : cell viability using neutral red and Alamar blue assays, apoptosis (Hoechst and Yopro-1 tests) and oxidative stress (Hydroethidin and dichlorofluorescein diacetate tests) generated by these products. The toxicological profiles of these products demonstrated once more the concentration-dependent cytotoxicity of BAC and confirmed the absence of toxicity with the new preservative, justifying the interest in developing the new anti glaucomatous formulation associated with this new preservative.